Grendene S.A (GRND3) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Grendene S.A (GRND3) has a cash flow conversion efficiency ratio of 0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$2.10 Million ≈ $412.84K USD) by net assets (R$4.05 Billion ≈ $794.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Grendene S.A - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Grendene S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read GRND3 current and long-term liabilities for a breakdown of total debt and financial obligations.
Grendene S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Grendene S.A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MBK Public Company Limited
BK:MBK-R
|
0.028x |
|
Suzhou Tianwo Science and Technology Co Ltd
SHE:002564
|
0.404x |
|
MedCap AB (publ)
ST:MCAP
|
0.104x |
|
Zhongzhu Medical Holdings Co Ltd
SHG:600568
|
0.016x |
|
Karnov Group AB
ST:KAR
|
0.023x |
|
Zhejiang Starry Pharm Co Ltd
SHG:603520
|
0.004x |
|
Runner Xiamen Corp
SHG:603408
|
0.071x |
|
Kura Oncology Inc
NASDAQ:KURA
|
0.673x |
Annual Cash Flow Conversion Efficiency for Grendene S.A (2003–2024)
The table below shows the annual cash flow conversion efficiency of Grendene S.A from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see Grendene S.A market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | R$4.04 Billion ≈ $792.91 Million |
R$702.74 Million ≈ $137.89 Million |
0.174x | -13.62% |
| 2023-12-31 | R$3.66 Billion ≈ $718.05 Million |
R$736.73 Million ≈ $144.56 Million |
0.201x | +63.89% |
| 2022-12-31 | R$4.36 Billion ≈ $856.32 Million |
R$536.08 Million ≈ $105.19 Million |
0.123x | -9.61% |
| 2021-12-31 | R$4.09 Billion ≈ $803.38 Million |
R$556.40 Million ≈ $109.17 Million |
0.136x | +427.94% |
| 2020-12-31 | R$4.23 Billion ≈ $830.04 Million |
R$108.89 Million ≈ $21.37 Million |
0.026x | -75.84% |
| 2019-12-31 | R$4.01 Billion ≈ $786.19 Million |
R$426.83 Million ≈ $83.75 Million |
0.107x | -23.71% |
| 2018-12-31 | R$3.47 Billion ≈ $679.90 Million |
R$483.83 Million ≈ $94.94 Million |
0.140x | -14.54% |
| 2017-12-31 | R$3.22 Billion ≈ $631.35 Million |
R$525.73 Million ≈ $103.16 Million |
0.163x | -15.72% |
| 2016-12-31 | R$2.92 Billion ≈ $573.36 Million |
R$566.47 Million ≈ $111.15 Million |
0.194x | +14.58% |
| 2015-12-31 | R$2.62 Billion ≈ $513.46 Million |
R$442.72 Million ≈ $86.87 Million |
0.169x | -18.79% |
| 2014-12-31 | R$2.33 Billion ≈ $456.78 Million |
R$484.96 Million ≈ $95.16 Million |
0.208x | +42.04% |
| 2013-12-31 | R$2.07 Billion ≈ $405.77 Million |
R$303.31 Million ≈ $59.51 Million |
0.147x | +48.74% |
| 2012-12-31 | R$1.95 Billion ≈ $383.32 Million |
R$192.64 Million ≈ $37.80 Million |
0.099x | +160.59% |
| 2011-12-31 | R$1.80 Billion ≈ $353.38 Million |
R$68.15 Million ≈ $13.37 Million |
0.038x | -80.56% |
| 2010-12-31 | R$1.68 Billion ≈ $328.80 Million |
R$326.23 Million ≈ $64.01 Million |
0.195x | +13.62% |
| 2009-12-31 | R$1.46 Billion ≈ $287.37 Million |
R$250.96 Million ≈ $49.24 Million |
0.171x | +14.56% |
| 2008-12-31 | R$1.32 Billion ≈ $258.63 Million |
R$197.16 Million ≈ $38.69 Million |
0.150x | -37.25% |
| 2007-12-31 | R$1.18 Billion ≈ $231.62 Million |
R$281.39 Million ≈ $55.21 Million |
0.238x | +28.21% |
| 2006-12-31 | R$979.23 Million ≈ $192.14 Million |
R$182.06 Million ≈ $35.72 Million |
0.186x | -45.68% |
| 2005-12-31 | R$851.17 Million ≈ $167.01 Million |
R$291.33 Million ≈ $57.16 Million |
0.342x | +35.99% |
| 2004-12-31 | R$737.29 Million ≈ $144.67 Million |
R$185.57 Million ≈ $36.41 Million |
0.252x | +6.68% |
| 2003-12-31 | R$692.73 Million ≈ $135.93 Million |
R$163.44 Million ≈ $32.07 Million |
0.236x | -- |
About Grendene S.A
Grendene S.A., together with its subsidiaries, engages in the development, production, distribution, and sale of plastic footwear for women, men, and children in Brazil and internationally. The company sells its products through its stores, franchised stores, and web commerce channels, as well as through commercial representatives and distributors under the Melissa, Grendha, Rider, Cartago, Ipane… Read more